Share this post on:

Product Name :
Sovilnesib

Search keywords :
Sovilnesib

drugId :
null

Target Vo:
Kinesin-like protein KIF18A

Target Vo Short Name :
KIF18A

Moa_Name:
Kinesin-like protein KIF18A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Amgen Inc

Active Company_Name :
Amgen Inc

Active Indication_Name:
Peritoneal Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PPAR alpha Antibody
CD40L Antibody
AIF Antibody (YA636): AIF Antibody (YA636) is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to AIF. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related